BG Medicine Inc.

Research from S. Galati and co-authors reveals new findings on pharmacological.
Biotech Week; 11/11/2009; 997 words; ...of different basal ganglia (BG) stations in rat models of Parkinson...show that an abnormal cortical/BG synchronization, at low frequency...Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main...Hydrochloride, Drugs, Pain Medicine, Parkinsonian Disorders, Pharmaceuticals...

Other News To Note.
BIOWORLD Today; 11/3/2009; 3066 words; ...New England Journal of Medicine describing the identification...o ARYx Therapeutics Inc., of Santa Clara, Calif...o Barrier Therapeutics Inc., of Princeton, N...and JP Morgan Securities Inc. o Biogen Idec Inc...from a Phase II study of BG-12, an oral fumarate...

JMP Securities Healthcare to Host Conference.
Health & Beauty Close-Up; 9/30/2009; 966 words; ...Pharmaceuticals, Inc. Ardea Biosciences, Inc. athenahealth, Inc. AtriCure, Inc. AVEO Pharmaceuticals, Inc. AVI BioPharma, Inc. BG Medicine, Inc. BioCryst Pharmaceuticals, Inc. Brookdale Senior Living Inc. Cadence Pharmaceuticals, Inc. ...

JMP Securities Healthcare Conference to Be Held in New York.(Conference news)
Business Wire; 9/29/2009; 868 words; ...Pharmaceuticals, Inc. Ardea Biosciences, Inc. athenahealth, Inc. AtriCure, Inc. AVEO Pharmaceuticals, Inc. AVI BioPharma, Inc. BG Medicine, Inc. BioCryst Pharmaceuticals, Inc. Brookdale Senior Living Inc. Cadence Pharmaceuticals, Inc. ...

Executives hope busy IPO week is precursor to rebound ; Positive reception could spark interest, revive moribund markets
The Boston Globe; 9/23/2009; 1019 words; ...Massachusetts companies such as BG Medicine Inc., Archemix Corp., GlassHouse Technologies Inc., and NameMedia Inc. prepared to...GlassHouse Technologies, Archemix, and BG Medicine did not respond when asked...